During the last three months, 6 analysts shared their evaluations of Lexicon Pharmaceuticals (NASDAQ:LXRX), revealing diverse outlooks from bullish to bearish. The following table summarizes their ...
THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of ...
Lexicon Pharmaceuticals will release Q2 2025 financial results on August 6, with a conference call scheduled for 8:30 a.m. ET. Lexicon Pharmaceuticals, Inc. announced that it will release its second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results